The Association of Common SNPs and Haplotypes in CETP Gene with HDL Cholesterol Levels in Latvian Population

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Radovica, Ilze ^a   Fridmanis, Davids ^a   Vaivade, Iveta ^a   Nikitina Zake, Liene ^a   Klovins, Janis ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CETP GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; LATVIA; MALE; POPULATION GENETICS; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATABASES, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HEREDITY; HUMANS; LATVIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84877642474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064191     Document Type: Article

References (50)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, et al. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79: 8-15.
2. Natarajan P, Ray KK, Cannon CP High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol 55: 1283-1299.
3. Wilson PW, Abbott RD, Castelli WP, (1988) High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8: 737-741.
4. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M,et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380: 572-580.
5. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE, (1993) Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328: 1150-1156.
6. Athanasiu L, Brown AA, Birkenaes AB, Mattingsdal M, Agartz I,et al. Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment - a cross-sectional naturalistic study. Psychiatry Res.
7. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
8. Jee SH, Sull JW, Lee JE, Shin C, Park J,et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet 87: 545-552.
9. Kathiresan S, Musunuru K, Orho-Melander M, (2008) Defining the spectrum of alleles that contribute to blood lipid concentrations in humans. Curr Opin Lipidol 19: 122-127.
10. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, et al. (2008) Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82: 139-149.
11. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169.
12. Chasman DI, Pare G, Zee RY, Parker AN, Cook NR, et al. (2008) Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet 1: 21-30.
13. Edmondson AC, Braund PS, Stylianou IM, Khera AV, Nelson CP,et al. Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol. Circ Cardiovasc Genet 4: 145-155.
14. Hiura Y, Shen CS, Kokubo Y, Okamura T, Morisaki T, et al. (2009) Identification of genetic markers associated with high-density lipoprotein-cholesterol by genome-wide screening in a Japanese population: the Suita study. Circ J 73: 1119-1126.
15. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197.
16. Khovidhunkit W, Chartyingcharoen P, Siriwong S, Limumpornpetch P, Plengpanich W Resequencing CETP, LIPC and LIPG Genes in Thai Subjects With Hyperalphalipoproteinemia. Am J Cardiol.
17. Ma L, Yang J, Runesha HB, Tanaka T, Ferrucci L,et al. Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data. BMC Med Genet 11: 55.
18. Ridker PM, Pare G, Parker AN, Zee RY, Miletich JP, et al. (2009) Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study. Circ Cardiovasc Genet 2: 26-33.
19. Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, et al. (2009) Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 119: 1042-1050.
20. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, et al. (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39: 513-516.
21. Ignatovica V, Latkovskis G, Peculis R, Megnis K, Schioth HB,et al. Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population. Mol Biol Rep 39: 1917-1925.
22. Burkhardt R, Kenny EE, Lowe JK, Birkeland A, Josowitz R, et al. (2008) Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler Thromb Vasc Biol 28: 2078-2084.
23. Heid IM, Boes E, Muller M, Kollerits B, Lamina C, et al. (2008) Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions. Circ Cardiovasc Genet 1: 10-20.
24. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65.
25. Kooner JS, Chambers JC, Aguilar-Salinas CA, Hinds DA, Hyde CL, et al. (2008) Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 40: 149-151.
26. Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, et al. (2008) A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322: 1702-1705.
27. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, et al (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41: 35-46.
28. Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, et al. (2008) LDL-cholesterol concentrations: a genome-wide association study. Lancet 371: 483-491.
29. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
30. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH,et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30: 2264-2276.
31. Barsh GS, Copenhaver GP, Gibson G, Williams SM Guidelines for genome-wide association studies. PLoS Genet 8: e1002812.
32. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
33. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
34. Gauderman W MJ (2009) QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies.
35. Thompson JF, Durham LK, Lira ME, Shear C, Milos PM, (2005) CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis 181: 45-53.
36. Thompson JF, Wood LS, Pickering EH, Dechairo B, Hyde CL, (2007) High-density genotyping and functional SNP localization in the CETP gene. J Lipid Res 48: 434-443.
37. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, et al. (2004) A review of CETP and its relation to atherosclerosis. J Lipid Res 45: 1967-1974.
38. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM,et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
39. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M, (2000) New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 20: 507-515.
40. Thompson JF, Lloyd DB, Lira ME, Milos PM, (2004) Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol. Clin Genet 66: 223-228.
41. Hirano K, Yamashita S, Kuga Y, Sakai N, Nozaki S, et al. (1995) Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 15: 1849-1856.
42. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, et al. (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97: 2917-2923.
43. Breslow JL, Ross D, McPherson J, Williams H, Kurnit D, et al. (1982) Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci U S A 79: 6861-6865.
44. Brewer HB Jr, Fairwell T, LaRue A, Ronan R, Houser A, et al. (1978) The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun 80: 623-630.
45. Martin S, Nicaud V, Humphries SE, Talmud PJ, (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637: 217-225.
46. Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP Jr, et al. (2004) Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA 291: 2821-2827.
47. Jonas A, (2000) Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529: 245-256.
48. Ishida T, Choi SY, Kundu RK, Spin J, Yamashita T, et al. (2004) Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 279: 45085-45092.
49. Lo JY, Smith LC, Chan L, (1995) Lipoprotein lipase: role of intramolecular disulfide bonds in enzyme catalysis. Biochem Biophys Res Commun 206: 266-271.
50. Spirin V, Schmidt S, Pertsemlidis A, Cooper RS, Cohen JC, et al. (2007) Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol. Am J Hum Genet 81: 1298-1303.